Abstract:Drug-induced blockade of the human ether-à-go-go-related gene (hERG) channel is today considered the main cause of cardiotoxicity in postmarketing surveillance. Hence, several ligand-based approaches were developed in the last years and are currently employed in the early stages of a drug discovery process for in silico cardiac safety assessment of drug candidates. Herein, we present the first structure-based classifiers able to discern hERG binders from nonbinders. LASSO regularized support vector machines were applied to integrate docking scores and protein–ligand interaction fingerprints. A total of 396 models were trained and validated based on: (i) high-quality experimental bioactivity information returned by 8337 curated compounds extracted from ChEMBL (version 25) and (ii) structural predictor data. Molecular docking simulations were performed using GLIDE and GOLD software programs and four different hERG structural models, namely, the recently published structures obtained by cryoelectron microscopy (PDB codes: 5VA1 and 7CN1) and two published homology models selected for comparison. Interestingly, some classifiers return performances comparable to ligand-based models in terms of area under the ROC curve (AUCMAX = 0.86 ± 0.01) and negative predictive values (NPVMAX = 0.81 ± 0.01), thus putting forward the herein proposed computational workflow as a valuable tool for predicting hERG-related cardiotoxicity without the limitations of ligand-based models, typically affected by low interpretability and a limited applicability domain. From a methodological point of view, our study represents the first example of a successful integration of docking scores and protein–ligand interaction fingerprints (IFs) through a support vector machine (SVM) LASSO regularized strategy. Finally, the study highlights the importance of using hERG structural models accounting for ligand-induced fit effects and allowed us to select the best-performing protein conformation (made available in the Supporting Information, SI) to be employed for a reliable structure-based prediction of hERG-related cardiotoxicity.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jcim.1c00744.Top views of the BS of all of the employed protein models and the number of active and inactive compounds as a consequence of the selected activity and inactivity thresholds (Figures S1 and S2 and Tables S1) (PDF)Kolmogorov–Smirnov test p-values summarizing the difference in docking score distributions between hERG binders and nonbinders, the SE and SP of all of the developed models, the BS volumes (Å3) of all of the used hERG models, and the interactions responsible for a lower IC50 based on the KS test performed on the IFs returned by all of the considered protein models (Tables S2–S6) (PDF)List of the compounds belonging to the hERG-DB, including SMILES strings and corresponding IC50 values (XLSX)Results of the performed docking simulations including docking scores and molecular interaction fingerprints (ZIP)Results of the performed docking simulations including molecular interaction fingerprints (ZIP)5VA1-IFD-1, 5VA1-IFD-2, 5VA1-IFD-3, 5VA1-IFD-4, and 5VA1-IFD-5 conformations as. pdb files (ZIP)This article has not yet been cited by other publications.

Prediction of Herg K+ Channel Blockage Using Deep Neural Networks

Machine learning and deep learning approaches for enhanced prediction of hERG blockade: a comprehensive QSAR modeling study

The non-waxy component of the armored-scale insect sheild.

HergSPred: Accurate Classification of hERG Blockers/Nonblockers with Machine-Learning Models

ADMET Evaluation in Drug Discovery. 16. Predicting Herg Blockers by Combining Multiple Pharmacophores and Machine Learning Approaches.

Admet Evaluation In Drug Discovery. 12. Development Of Binary Classification Models For Prediction Of Herg Potassium Channel Blockage

Investigating cardiotoxicity related with hERG channel blockers using molecular fingerprints and graph attention mechanism

Virtual screening of DrugBank database for hERG blockers using topological Laplacian-assisted AI models

Recent Developments in Computational Prediction of Herg Blockage

Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays

Predicting hERG channel blockers with directed message passing neural networks

The Study on the hERG Blocker Prediction Using Chemical Fingerprint Analysis

Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity

Risk factors for acquisition of endemic blastomycosis.

hERGBoost: A gradient boosting model for quantitative IC50 prediction of hERG channel blockers

Development of models for predicting Torsade de Pointes cardiac arrhythmias using perceptron neural networks

Structure-Based Prediction of hERG-Related Cardiotoxicity: A Benchmark Study

ToxTree: descriptor-based machine learning models for both hERG and Nav1.5 cardiotoxicity liability predictions

Enhancing hERG Risk Assessment with Interpretable Classificatory and Regression Models

CardioDPi: An explainable deep-learning model for identifying cardiotoxic chemicals targeting hERG, Cav1.2, and Nav1.5 channels

A stacking ensemble machine learning model for evaluating cardiac toxicity of drugs based on in silico biomarkers